График акции Genelux Corporation
Расширенный график
Простой график
О компании Genelux Corporation
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. подробнее| IPO date | 2023-01-26 |
|---|---|
| ISIN | US36870H1032 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.genelux.com |
| Цена ао | 3.2 |
| Изменение цены за день: | 0% (2.46) |
|---|---|
| Изменение цены за неделю: | +6.49% (2.31) |
| Изменение цены за месяц: | -34.05% (3.73) |
| Изменение цены за 3 месяца: | +7.42% (2.29) |
| Изменение цены за полгода: | -12.46% (2.81) |
| Изменение цены за год: | -31.95% (3.615) |
| Изменение цены с начала года: | +8.37% (2.27) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Blackrock Inc. | 1196123 | 4.48 |
| Vanguard Group Inc | 980993 | 3.67 |
| Geode Capital Management, LLC | 386634 | 1.45 |
| State Street Corporation | 231065 | 0.86 |
| AE Wealth Management LLC | 194875 | 0.73 |
| Northern Trust Corporation | 160816 | 0.6 |
| Provident Wealth Management, LLC | 157137 | 0.59 |
| Charles Schwab Investment Management, Inc. | 149604 | 0.56 |
| Bank Of New York Mellon Corporation | 53841 | 0.2 |
| AMG National Trust Bank | 50346 | 0.19 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Mr. Thomas Zindrick J.D. | Chairman, CEO & President | 570.99k | 1959 (66 лет) |
| Mr. Sean Ryder J.D. | General Counsel & Corporate Secretary | 380k | 1969 (56 лет) |
| Ms. Lourie S. Zak | Chief Financial Officer | 346.19k | 1963 (62 года) |
| Dr. Joseph Cappello Ph.D. | Chief Technical Officer | 213.08k | 1957 (68 лет) |
| Dr. Yong Yu Ph.D. | Senior Vice President of Clinical Development | 242.62k | 1971 (54 года) |
| Prof. Paul Scigalla M.D., Ph.D. | Chief Medical Officer | N/A | 1945 (80 лет) |
| Mr. Ralph Smalling B.Sc. | VP & Head of Regulatory Affairs | N/A | 1957 (68 лет) |
| Ms. Caroline Jewett | VP & Head of Quality | 269.26k | 1965 (60 лет) |
Адрес: United States, Westlake Village. CA, 2625 Townsgate Road - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.genelux.com
Сайт: https://www.genelux.com
